Compositions et procédés permettant de caractériser, de réguler, de diagnostiquer et de traiter des cancers

Compositions and methods for characterizing, regulating, diagnosing, and treating cancer

Abstract

La présente invention se rapporte à des compositions et à des procédés permettant de caractériser, de réguler, de diagnostiquer et de traiter des cancers. Par exemple, l'invention concerne des compositions et des procédés permettant d'inhiber la tumorigenèse de certaines catégories de cellules cancéreuses, notamment de cellules cancéreuses du sein, et de prévenir les métastases. L'invention a également trait à des systèmes et à des procédés permettant d'identifier des composés qui régulent la tumorigenèse.
The present invention relates to compositions and methods for characterizing, regulating, diagnosing, and treating cancer. For example, the present invention provides compositions and methods for inhibiting tumorigenesis of certain classes of cancer cells, including breast cancer cells and preventing metastasis. The present invention also provides systems and methods for identifying compounds that regulate tumorigenesis.

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (2)

    Publication numberPublication dateAssigneeTitle
    WO-0218544-A2March 07, 2002Loyola University ChicagoProcedes et reactifs permettant la formation d'une barriere epitheliale et traitement d'affections cutanees malignes et benignes par modulation de la voie notch
    WO-03050502-A2June 19, 2003Regents Of The University Of MichiganIdentification et caracterisation prospectives des cellules souches cancereuses du sein

NO-Patent Citations (1)

    Title
    See also references of EP 1718767A4

Cited By (29)

    Publication numberPublication dateAssigneeTitle
    EP-3153862-A1April 12, 2017The Regents of the University of MichiganAnti-cxcr1-zusammensetzungen und verfahren
    US-7919092-B2April 05, 2011Oncomed Pharmaceuticals, Inc.Antibodies to notch receptors
    US-8088617-B2January 03, 2012Oncomed Pharmaceuticals, Inc.Antibodies that bind the glutamate ligand binding region of Notch1
    US-8206713-B2June 26, 2012Oncomed Pharmaceuticals, Inc.Method of treating cancer using antibodies to a non-ligand binding region of NOTCH2
    US-8226943-B2July 24, 2012Oncomed Pharmaceuticals, Inc.Antibodies to notch receptors
    US-8404237-B2March 26, 2013OncoMed Pharamaceuticals, Inc.Antibodies to the NOTCH1 receptor
    US-8425903-B2April 23, 2013Oncomed Pharmaceuticals, Inc.Methods of treatment by administering antibodies to notch receptors
    US-8435513-B2May 07, 2013Oncomed Pharmaceuticals, Inc.NOTCH1 receptor antibodies and methods of treatment
    US-8460661-B2June 11, 2013Oncomed Pharmaceuticals, Inc.Methods of using antibodies that bind the glutamate ligand binding region of Notch1
    US-8784811-B2July 22, 2014Oncomed Pharmaceuticals, Inc.Method of treating cancer using antibodies to a non-ligand binding region of NOTCH1
    US-8834875-B2September 16, 2014Oncomed Pharmaceuticals, Inc.Notch1 binding agents and methods of use thereof
    US-8921106-B2December 30, 2014Oncomed Pharmaceuticals, Inc.Antibodies that bind the glutamate ligand binding region of NOTCH3
    US-8940301-B2January 27, 2015The Regents Of The University Of MichiganBreast tumor treatment with anti-CXCR1 compositions
    US-8945547-B2February 03, 2015Oncomed Pharmaceuticals, Inc.Notch1 receptor antibodies and methods of treatment
    US-8945873-B2February 03, 2015Oncomed Pharmaceuticals, Inc.Polynucleotides encoding Notch receptor antibodies
    US-8945874-B2February 03, 2015Oncomed Pharmaceuticals, Inc.Polynucleotides encoding NOTCH1 receptor antibodies
    US-8980260-B2March 17, 2015Oncomed Pharmaceuticals, Inc.Monoclonal antibody that binds human notch2 and notch3
    US-9089556-B2July 28, 2015The Regents Of The University Of MichiganMethod for treating cancer using an antibody that inhibits notch4 signaling
    US-9132189-B2September 15, 2015Oncomed Pharmaceuticals, Inc.Notch1 binding agents and methods of use thereof
    US-9499613-B2November 22, 2016Oncomed Pharmaceuticals, Inc.Notch1 receptor binding agents and methods of use thereof
    US-9505832-B2November 29, 2016Oncomed Pharmaceuticals, Inc.Method of treating cancer by administering a monoclonal antibody that binds human NOTCH2 and NOTCH3
    US-9527921-B2December 27, 2016Eisai R&D Management Co., Ltd.Anti human Notch4 antibody
    US-9606124-B2March 28, 2017The Regents Of The University Of MichiganMethods of detecting and treating stem-cell containing solid tumors
    US-9617340-B2April 11, 2017Oncomed Pharmaceuticals, Inc.Compositions and methods for diagnosing and treating cancer
    US-9676865-B2June 13, 2017Oncomed Pharmaceuticals, Inc.Antibodies to a non-ligand binding region of at least two NOTCH receptors
    WO-2008091641-A2July 31, 2008Oncomed Pharmaceuticals, Inc.Compositions and methods for diagnosing and treating cancer
    WO-2008091641-A3December 04, 2008Oncomed Pharm Inc, Austin Gurney, Aaron Sato, Maureen Fitch-BruhnsCompositions et procédés utilisés pour le diagnostic et le traitement du cancer
    WO-2008122794-A2October 16, 2008Imperial Innovations LimitedBreast cancer methods, medicaments and agents
    WO-2008122794-A3April 02, 2009Raoul Charles Coombes, Imp Innovations Ltd, Martin SladeBreast cancer methods, medicaments and agents